Fio Corporation - CEO, Dr. Michael Greenberg

" Scryb (CSE:SCYB) and Fio announce the launch of FlyClear™ with LifeLabs

Scryb (SCYB) and Fio Corporation have launched FlyClear™ with LifeLabs® providing rapid COVID-19 pre-departure testing for those flying internationally.

" Claritas (TSXV:CLAS) secures $5 million financing with Alumina Partners

Claritas Pharmaceuticals (CLAS) has entered into an agreement with Alumina Partners to provide up to $5 million in equity financing for two years.

" Claritas (TSXV:CLAS) acquires license to develop and commercialize R-107

Claritas Pharmaceuticals (CLAS) has entered a License Amendment with Salzman Group Inc., and its subsidiaries.

" Relevium Technologies (TSXV:RLV) secures two P.P.E. contracts

Relevium (RLV) has secured two P.P.E. contracts totalling C$16M resulting in record yearly revenue.

" Therma Bright’s (TSXV:THRM) COVID-19 saliva test detects Omicron variant

Therma Bright’s (THRM) AcuVid COVID-19 rapid antigen saliva test has detected the Omicron variant.

" XORTX Therapeutics (TSXV:XTRX) reveals study of hospitalized COVID-19 patients

XORTX (XRTX) has shared studies from its article, “Prevalence and Outcomes Associated with Hyperuricemia in Hospitalized Patients with COVID-19”.
covid test

" Visionstate’s (TSXV:VIS) IoT technology pivotal in fight against COVID-19

Visionstate IoT Inc. is positioning its technology as a key component in the fight against COVID-19.

" StageZero Life Sciences (TSX:SZLS) introduces COVID-19 PCR testing for travellers

StageZero Life Sciences Ltd. (SZLS) announces the availability of its BORDERPASS™ COVID-19 RT-PCR saliva test.
Resverlogix - CEO, Donald McCaffrey.

" Resverlogix (TSX:RVX) in discussions for COVID-19 clinical studies in Morocco

Resverlogix (RVX) is in discussions to launch Phase 2 COVID-19 clinical studies with Apabetalone in Morocco.
XORTX Therapeutics - CEO, Allen Davidoff.

" XORTX Therapeutics (CSE:XRX) announces Nasdaq listing and $12 million public offering

XORTX (XRX) begins trading today on the Nasdaq Capital Market in conjunction with a US$12 million public offering.